15 research outputs found
Recommended from our members
DNA methylation changes in African American women with a history of preterm birth from the InterGEN study
Background
Preterm birth (< 37 weeks’ gestation) is a common outcome of pregnancy that has been associated with increased risk of cardiovascular disease for women later in life. Little is known about the physiologic mechanisms underlying this risk. To date, no studies have evaluated if differences in DNA methylation (DNAm) among women who experience preterm birth are short-term or if they persist and are associated with subsequent cardiovascular sequelae or other health disorders. The purpose of this study was to examine long-term epigenetic effects of preterm birth in African American mothers (n = 182) from the InterGEN Study (2014–2019). In this study, we determine if differences in DNAm exist between women who reported a preterm birth in the last 3–5 years compared to those who had full-term births by using two different approaches: epigenome-wide association study (EWAS) and genome-wide co-methylation analyses.
Results
Though no significant CpG sites were identified using the EWAS approach, we did identify significant modules of co-methylation associated with preterm birth. Co-methylation analyses showed correlations with preterm birth in gene ontology and KEGG pathways. Functional annotation analysis revealed enrichment for pathways related to central nervous system and sensory perception. No association was observed between DNAm age and preterm birth, though larger samples are needed to confirm this further.
Conclusions
We identified differentially methylated gene networks associated with preterm birth in African American women 3–5 years after birth, including pathways related to neurogenesis and sensory processing. More research is needed to understand better these associations and replicate them in an independent cohort. Further study should be done in this area to elucidate mechanisms linking preterm birth and later epigenomic changes that may contribute to the development of health disorders and maternal mood and well-being
Central and Peripheral Immune Dysregulation in Posttraumatic Stress Disorder: Convergent Multi-Omics Evidence
Posttraumatic stress disorder (PTSD) is a chronic and multifactorial disorder with a prevalence ranging between 6–10% in the general population and ~35% in individuals with high lifetime trauma exposure. Growing evidence indicates that the immune system may contribute to the etiology of PTSD, suggesting the inflammatory dysregulation as a hallmark feature of PTSD. However, the potential interplay between the central and peripheral immune system, as well as the biological mechanisms underlying this dysregulation remain poorly understood. The activation of the HPA axis after trauma exposure and the subsequent activation of the inflammatory system mediated by glucocorticoids is the most common mechanism that orchestrates an exacerbated immunological response in PTSD. Recent high-throughput analyses in peripheral and brain tissue from both humans with and animal models of PTSD have found that changes in gene regulation via epigenetic alterations may participate in the impaired inflammatory signaling in PTSD. The goal of this review is to assess the role of the inflammatory system in PTSD across tissue and species, with a particular focus on the genomics, transcriptomics, epigenomics, and proteomics domains. We conducted an integrative multi-omics approach identifying TNF (Tumor Necrosis Factor) signaling, interleukins, chemokines, Toll-like receptors and glucocorticoids among the common dysregulated pathways in both central and peripheral immune systems in PTSD and propose potential novel drug targets for PTSD treatment
Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex
Abstract Opioid use disorder (OUD) is influenced by genetic and environmental factors. While recent research suggests epigenetic disturbances in OUD, this is mostly limited to DNA methylation (5mC). DNA hydroxymethylation (5hmC) has been widely understudied. We conducted a multi-omics profiling of OUD in a male cohort, integrating neuronal-specific 5mC and 5hmC as well as gene expression profiles from human postmortem orbitofrontal cortex (OUD = 12; non-OUD = 26). Single locus methylomic analysis and co-methylation analysis showed a higher number of OUD-associated genes and gene networks for 5hmC compared to 5mC; these were enriched for GPCR, Wnt, neurogenesis, and opioid signaling. 5hmC marks also showed a higher correlation with gene expression patterns and enriched for GWAS of psychiatric traits. Drug interaction analysis revealed interactions with opioid-related drugs, some used as OUD treatments. Our multi-omics findings suggest an important role of 5hmC and reveal loci epigenetically dysregulated in OFC neurons of individuals with OUD
Identification of bovine CpG SNPs as potential targets for epigenetic regulation via DNA methylation.
Methylation patterns established and maintained at CpG sites may be altered by single nucleotide polymorphisms (SNPs) within these sites and may affect the regulation of nearby genes. Our aims were to: 1) identify and generate a database of SNPs potentially subject to epigenetic control by DNA methylation via their involvement in creating, removing or displacing CpG sites (meSNPs), and; 2) investigate the association of these meSNPs with CpG islands (CGIs), and with methylation profiles of DNA extracted from tissues from cattle with divergent feed efficiencies detected using MIRA-Seq. Using the variant annotation for 56,969,697 SNPs identified in Run5 of the 1000 Bull Genomes Project and the UMD3.1.1 bovine reference genome sequence assembly, we identified and classified 12,836,763 meSNPs according to the nature of variation created at CpGs. The majority of the meSNPs were located in intergenic regions (68%) or introns (26.3%). We found an enrichment (p<0.01) of meSNPs located in CGIs relative to the genome as a whole, and also in differentially methylated sequences in tissues from animals divergent for feed efficiency. Seven meSNPs, located in differentially methylated regions, were fixed for methylation site creating (MSC) or destroying (MSD) alleles in the differentially methylated genomic sequences of animals differing in feed efficiency. These meSNPs may be mechanistically responsible for creating or deleting methylation targets responsible for the differential expression of genes underlying differences in feed efficiency. Our methyl SNP database (dbmeSNP) is useful for identifying potentially functional "epigenetic polymorphisms" underlying variation in bovine phenotypes
Image7_Neuronal-specific methylome and hydroxymethylome analysis reveal significant loci associated with alcohol use disorder.JPEG
Background: Alcohol use disorder (AUD) is a complex condition associated with adverse health consequences that affect millions of individuals worldwide. Epigenetic modifications, including DNA methylation (5Â mC), have been associated with AUD and other alcohol-related traits. Epigenome-wide association studies (EWAS) have identified differentially methylated genes associated with AUD in human peripheral and brain tissue. More recently, epigenetic studies of AUD have also evaluated DNA hydroxymethylation (5Â hmC) in the human brain. However, most of the epigenetic work in postmortem brain tissue has examined bulk tissue. In this study, we investigated neuronal-specific 5Â mC and 5Â hmC alterations at CpG sites associated with AUD in the human orbitofrontal cortex (OFC).Methods: Neuronal nuclei from the OFC were evaluated in 34 human postmortem brain samples (10 AUD, 24 non-AUD). Reduced representation oxidative bisulfite sequencing was used to assess 5Â mC and 5Â hmC at the genome-wide level. Differential 5Â mC and 5Â hmC were evaluated using the methylKit R package and significance was set at false discovery rate 2. Functional enrichment analyses were performed, and gene-level convergence was evaluated in an independent dataset that assessed 5Â mC and 5Â hmC of AUD in bulk cortical tissue.Results: We identified 417 5Â mC and 363Â 5hmC significant differential CpG sites associated with AUD, with 59% in gene promoters. Some of the identified genes have been previously implicated in alcohol consumption, including SYK, DNMT3A for 5Â mC, GAD1, DLX1, DLX2, for 5Â hmC and GATA4 in both. Convergence with a previous AUD 5Â mC and 5Â hmC study was observed for 28 genes. We also identified 5 and 35 differential regions for 5Â mC and 5Â hmC, respectively. Lastly, GWAS enrichment analysis showed an association with AUD for differential 5Â mC genes.Discussion: This study reveals neuronal-specific methylome and hydroxymethylome dysregulation associated with AUD, identifying both previously reported and potentially novel gene associations with AUD. Our findings provide new insights into the epigenomic dysregulation of AUD in the human brain.</p
Image8_Neuronal-specific methylome and hydroxymethylome analysis reveal significant loci associated with alcohol use disorder.JPEG
Background: Alcohol use disorder (AUD) is a complex condition associated with adverse health consequences that affect millions of individuals worldwide. Epigenetic modifications, including DNA methylation (5Â mC), have been associated with AUD and other alcohol-related traits. Epigenome-wide association studies (EWAS) have identified differentially methylated genes associated with AUD in human peripheral and brain tissue. More recently, epigenetic studies of AUD have also evaluated DNA hydroxymethylation (5Â hmC) in the human brain. However, most of the epigenetic work in postmortem brain tissue has examined bulk tissue. In this study, we investigated neuronal-specific 5Â mC and 5Â hmC alterations at CpG sites associated with AUD in the human orbitofrontal cortex (OFC).Methods: Neuronal nuclei from the OFC were evaluated in 34 human postmortem brain samples (10 AUD, 24 non-AUD). Reduced representation oxidative bisulfite sequencing was used to assess 5Â mC and 5Â hmC at the genome-wide level. Differential 5Â mC and 5Â hmC were evaluated using the methylKit R package and significance was set at false discovery rate 2. Functional enrichment analyses were performed, and gene-level convergence was evaluated in an independent dataset that assessed 5Â mC and 5Â hmC of AUD in bulk cortical tissue.Results: We identified 417 5Â mC and 363Â 5hmC significant differential CpG sites associated with AUD, with 59% in gene promoters. Some of the identified genes have been previously implicated in alcohol consumption, including SYK, DNMT3A for 5Â mC, GAD1, DLX1, DLX2, for 5Â hmC and GATA4 in both. Convergence with a previous AUD 5Â mC and 5Â hmC study was observed for 28 genes. We also identified 5 and 35 differential regions for 5Â mC and 5Â hmC, respectively. Lastly, GWAS enrichment analysis showed an association with AUD for differential 5Â mC genes.Discussion: This study reveals neuronal-specific methylome and hydroxymethylome dysregulation associated with AUD, identifying both previously reported and potentially novel gene associations with AUD. Our findings provide new insights into the epigenomic dysregulation of AUD in the human brain.</p
Image6_Neuronal-specific methylome and hydroxymethylome analysis reveal significant loci associated with alcohol use disorder.JPEG
Background: Alcohol use disorder (AUD) is a complex condition associated with adverse health consequences that affect millions of individuals worldwide. Epigenetic modifications, including DNA methylation (5Â mC), have been associated with AUD and other alcohol-related traits. Epigenome-wide association studies (EWAS) have identified differentially methylated genes associated with AUD in human peripheral and brain tissue. More recently, epigenetic studies of AUD have also evaluated DNA hydroxymethylation (5Â hmC) in the human brain. However, most of the epigenetic work in postmortem brain tissue has examined bulk tissue. In this study, we investigated neuronal-specific 5Â mC and 5Â hmC alterations at CpG sites associated with AUD in the human orbitofrontal cortex (OFC).Methods: Neuronal nuclei from the OFC were evaluated in 34 human postmortem brain samples (10 AUD, 24 non-AUD). Reduced representation oxidative bisulfite sequencing was used to assess 5Â mC and 5Â hmC at the genome-wide level. Differential 5Â mC and 5Â hmC were evaluated using the methylKit R package and significance was set at false discovery rate 2. Functional enrichment analyses were performed, and gene-level convergence was evaluated in an independent dataset that assessed 5Â mC and 5Â hmC of AUD in bulk cortical tissue.Results: We identified 417 5Â mC and 363Â 5hmC significant differential CpG sites associated with AUD, with 59% in gene promoters. Some of the identified genes have been previously implicated in alcohol consumption, including SYK, DNMT3A for 5Â mC, GAD1, DLX1, DLX2, for 5Â hmC and GATA4 in both. Convergence with a previous AUD 5Â mC and 5Â hmC study was observed for 28 genes. We also identified 5 and 35 differential regions for 5Â mC and 5Â hmC, respectively. Lastly, GWAS enrichment analysis showed an association with AUD for differential 5Â mC genes.Discussion: This study reveals neuronal-specific methylome and hydroxymethylome dysregulation associated with AUD, identifying both previously reported and potentially novel gene associations with AUD. Our findings provide new insights into the epigenomic dysregulation of AUD in the human brain.</p
Image2_Neuronal-specific methylome and hydroxymethylome analysis reveal significant loci associated with alcohol use disorder.JPEG
Background: Alcohol use disorder (AUD) is a complex condition associated with adverse health consequences that affect millions of individuals worldwide. Epigenetic modifications, including DNA methylation (5Â mC), have been associated with AUD and other alcohol-related traits. Epigenome-wide association studies (EWAS) have identified differentially methylated genes associated with AUD in human peripheral and brain tissue. More recently, epigenetic studies of AUD have also evaluated DNA hydroxymethylation (5Â hmC) in the human brain. However, most of the epigenetic work in postmortem brain tissue has examined bulk tissue. In this study, we investigated neuronal-specific 5Â mC and 5Â hmC alterations at CpG sites associated with AUD in the human orbitofrontal cortex (OFC).Methods: Neuronal nuclei from the OFC were evaluated in 34 human postmortem brain samples (10 AUD, 24 non-AUD). Reduced representation oxidative bisulfite sequencing was used to assess 5Â mC and 5Â hmC at the genome-wide level. Differential 5Â mC and 5Â hmC were evaluated using the methylKit R package and significance was set at false discovery rate 2. Functional enrichment analyses were performed, and gene-level convergence was evaluated in an independent dataset that assessed 5Â mC and 5Â hmC of AUD in bulk cortical tissue.Results: We identified 417 5Â mC and 363Â 5hmC significant differential CpG sites associated with AUD, with 59% in gene promoters. Some of the identified genes have been previously implicated in alcohol consumption, including SYK, DNMT3A for 5Â mC, GAD1, DLX1, DLX2, for 5Â hmC and GATA4 in both. Convergence with a previous AUD 5Â mC and 5Â hmC study was observed for 28 genes. We also identified 5 and 35 differential regions for 5Â mC and 5Â hmC, respectively. Lastly, GWAS enrichment analysis showed an association with AUD for differential 5Â mC genes.Discussion: This study reveals neuronal-specific methylome and hydroxymethylome dysregulation associated with AUD, identifying both previously reported and potentially novel gene associations with AUD. Our findings provide new insights into the epigenomic dysregulation of AUD in the human brain.</p
Image9_Neuronal-specific methylome and hydroxymethylome analysis reveal significant loci associated with alcohol use disorder.jpg
Background: Alcohol use disorder (AUD) is a complex condition associated with adverse health consequences that affect millions of individuals worldwide. Epigenetic modifications, including DNA methylation (5Â mC), have been associated with AUD and other alcohol-related traits. Epigenome-wide association studies (EWAS) have identified differentially methylated genes associated with AUD in human peripheral and brain tissue. More recently, epigenetic studies of AUD have also evaluated DNA hydroxymethylation (5Â hmC) in the human brain. However, most of the epigenetic work in postmortem brain tissue has examined bulk tissue. In this study, we investigated neuronal-specific 5Â mC and 5Â hmC alterations at CpG sites associated with AUD in the human orbitofrontal cortex (OFC).Methods: Neuronal nuclei from the OFC were evaluated in 34 human postmortem brain samples (10 AUD, 24 non-AUD). Reduced representation oxidative bisulfite sequencing was used to assess 5Â mC and 5Â hmC at the genome-wide level. Differential 5Â mC and 5Â hmC were evaluated using the methylKit R package and significance was set at false discovery rate 2. Functional enrichment analyses were performed, and gene-level convergence was evaluated in an independent dataset that assessed 5Â mC and 5Â hmC of AUD in bulk cortical tissue.Results: We identified 417 5Â mC and 363Â 5hmC significant differential CpG sites associated with AUD, with 59% in gene promoters. Some of the identified genes have been previously implicated in alcohol consumption, including SYK, DNMT3A for 5Â mC, GAD1, DLX1, DLX2, for 5Â hmC and GATA4 in both. Convergence with a previous AUD 5Â mC and 5Â hmC study was observed for 28 genes. We also identified 5 and 35 differential regions for 5Â mC and 5Â hmC, respectively. Lastly, GWAS enrichment analysis showed an association with AUD for differential 5Â mC genes.Discussion: This study reveals neuronal-specific methylome and hydroxymethylome dysregulation associated with AUD, identifying both previously reported and potentially novel gene associations with AUD. Our findings provide new insights into the epigenomic dysregulation of AUD in the human brain.</p
Table1_Neuronal-specific methylome and hydroxymethylome analysis reveal significant loci associated with alcohol use disorder.XLSX
Background: Alcohol use disorder (AUD) is a complex condition associated with adverse health consequences that affect millions of individuals worldwide. Epigenetic modifications, including DNA methylation (5Â mC), have been associated with AUD and other alcohol-related traits. Epigenome-wide association studies (EWAS) have identified differentially methylated genes associated with AUD in human peripheral and brain tissue. More recently, epigenetic studies of AUD have also evaluated DNA hydroxymethylation (5Â hmC) in the human brain. However, most of the epigenetic work in postmortem brain tissue has examined bulk tissue. In this study, we investigated neuronal-specific 5Â mC and 5Â hmC alterations at CpG sites associated with AUD in the human orbitofrontal cortex (OFC).Methods: Neuronal nuclei from the OFC were evaluated in 34 human postmortem brain samples (10 AUD, 24 non-AUD). Reduced representation oxidative bisulfite sequencing was used to assess 5Â mC and 5Â hmC at the genome-wide level. Differential 5Â mC and 5Â hmC were evaluated using the methylKit R package and significance was set at false discovery rate 2. Functional enrichment analyses were performed, and gene-level convergence was evaluated in an independent dataset that assessed 5Â mC and 5Â hmC of AUD in bulk cortical tissue.Results: We identified 417 5Â mC and 363Â 5hmC significant differential CpG sites associated with AUD, with 59% in gene promoters. Some of the identified genes have been previously implicated in alcohol consumption, including SYK, DNMT3A for 5Â mC, GAD1, DLX1, DLX2, for 5Â hmC and GATA4 in both. Convergence with a previous AUD 5Â mC and 5Â hmC study was observed for 28 genes. We also identified 5 and 35 differential regions for 5Â mC and 5Â hmC, respectively. Lastly, GWAS enrichment analysis showed an association with AUD for differential 5Â mC genes.Discussion: This study reveals neuronal-specific methylome and hydroxymethylome dysregulation associated with AUD, identifying both previously reported and potentially novel gene associations with AUD. Our findings provide new insights into the epigenomic dysregulation of AUD in the human brain.</p